BIOMAT Database Logo BIOMAT Database Logo

Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives. 2011

Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, 8, Lavrent'ev avenue, 630090 Novosibirsk, Russian Federation. evg_log@niboch.nsc.ru

Triterpenoids are used for medicinal purposes in many countries. Some, such as oleanolic and glycyrrhetinic acids, are known to be anti-inflammatory and anticarcinogenic. However, the biological activities of these naturally occurring molecules against their particular targets are weak, so the synthesis of new synthetic analogues with enhanced potency is needed. By combining modifications to both the A and C rings of 18βH-glycyrrhetinic acid, the novel synthetic derivative methyl 2-cyano-3,12-dioxo-18βH-olean-9(11),1(2)-dien-30-oate was obtained. This derivative displays high antiproliferative activity in cancer cells, including a cell line with a multidrug-resistance phenotype. It causes cell death by inducing the intrinsic caspase-dependent apoptotic pathway.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006034 Glycyrrhetinic Acid An oleanolic acid from GLYCYRRHIZA that has some antiallergic, antibacterial, and antiviral properties. It is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation. Enoxolone,Glycyrrhetic Acid,Rhetinic Acid,Uralenic Acid,Arthrodont,Glyciram,Glycyram,Jintan,Po 12,12, Po,Acid, Glycyrrhetic,Acid, Glycyrrhetinic,Acid, Rhetinic,Acid, Uralenic
D006035 Glycyrrhiza A genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivative, CARBENOXOLONE. Licorice,Glycyrrhiza glabra,Liquorice,Licorices,Liquorices
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
February 2019, Molecules (Basel, Switzerland),
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
November 2010, Bioorganic & medicinal chemistry,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis and Antiproliferative Activity of Novel A-Ring Cleaved Glycyrrhetinic Acid Derivatives.
August 2019, Molecules (Basel, Switzerland),
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
[Design, synthesis and antiproliferative activity in cancer cells of novel 18β-glycyrrhetinic acid derivatives].
October 2015, Yao xue xue bao = Acta pharmaceutica Sinica,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Tormentic acid derivatives: synthesis and apoptotic activity.
October 2012, European journal of medicinal chemistry,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
August 2014, Chemical biology & drug design,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
September 2019, European journal of medicinal chemistry,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
November 2011, European journal of medicinal chemistry,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis, Antiviral, and Antibacterial Activity of the Glycyrrhizic Acid and Glycyrrhetinic Acid Derivatives.
January 2022, Russian journal of bioorganic chemistry,
Evgeniya B Logashenko, and Oksana V Salomatina, and A V Markov, and Dina V Korchagina, and Nariman F Salakhutdinov, and Genrikh A Tolstikov, and Valentin V Vlassov, and Marina A Zenkova
Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives.
October 2023, International journal of molecular sciences,
Copied contents to your clipboard!